Literature DB >> 16672787

Venous oximetry.

Gernot Marx1, Konrad Reinhart.   

Abstract

PURPOSE OF REVIEW: Mixed venous and central venous oxygen saturations reflect the balance between oxygen requirement and oxygen delivery, and thus may be used to assess the adequacy of tissue oxygenation. This review discusses recent data on the impact of using venous oximetry by obtaining mixed venous oxygen saturation or central venous oxygen saturation as useful monitoring parameters in critically ill patients. RECENT
FINDINGS: Monitoring of changes in the central venous oxygen saturation after major surgery has been shown to be associated with outcome. Furthermore, early goal-directed therapy for patients with severe sepsis or septic shock, which includes treatment goals for mean arterial pressure, central venous pressure, and central venous oxygen saturation, was able to increase survival in these patients. In contrast, pulmonary artery catheter usage does not affect outcome in critically ill patients.
SUMMARY: Early goal-directed therapy should be implemented in the initial resuscitation of septic patients. Central venous saturation may have prognostic significance following major surgery. Further evaluation of peri-operative trends in central venous saturation is required. Measurement of central venous oxygen saturation can easily be applied in intensive care unit patients and offers a useful, indirect indicator for the adequacy of tissue oxygenation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672787     DOI: 10.1097/01.ccx.0000224872.09077.dc

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  20 in total

Review 1.  [Organ protective intensive care treatment and simulation-based training].

Authors:  J W Rey; T Ott; D Bösebeck; S Welschehold; P R Galle; C Werner
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 2.  [Haemodynamic monitoring in the perioperative phase. Available systems, practical application and clinical data].

Authors:  U Wittkowski; C Spies; M Sander; J Erb; A Feldheiser; C von Heymann
Journal:  Anaesthesist       Date:  2009-08       Impact factor: 1.041

3.  Oxygen saturation measurements of the retinal vasculature in treated asymmetrical primary open-angle glaucoma using hyperspectral imaging.

Authors:  D J Mordant; I Al-Abboud; G Muyo; A Gorman; A R Harvey; A I McNaught
Journal:  Eye (Lond)       Date:  2014-07-25       Impact factor: 3.775

Review 4.  [Volume replacement in intensive care medicine].

Authors:  B Nohé; A Ploppa; V Schmidt; K Unertl
Journal:  Anaesthesist       Date:  2011-05       Impact factor: 1.041

Review 5.  Minimally invasive monitoring of cardiac output in the cardiac surgery intensive care unit.

Authors:  Jamal A Alhashemi; Maurizio Cecconi; Giorgio della Rocca; Maxime Cannesson; Christoph K Hofer
Journal:  Curr Heart Fail Rep       Date:  2010-09

6.  Optimization of oxygen delivery in a Jehovah's Witness with severe anaemia after postpartum haemorrhage.

Authors:  LaVone Simmons; Alyssa Stephenson-Famy; Thomas Easterling
Journal:  Obstet Med       Date:  2011-12-14

7.  Early hemodynamic assessment and treatment of elderly patients in the medical ICU.

Authors:  Gorazd Voga; Lucija Gabršček-Parežnik
Journal:  Wien Klin Wochenschr       Date:  2016-11-28       Impact factor: 1.704

8.  Partitioning standard base excess: a new approach.

Authors:  Thomas John Morgan
Journal:  J Clin Monit Comput       Date:  2011-11-20       Impact factor: 2.502

9.  Evaluation and prognostic value of Cv-aCO2/Da-vO2 in patients with septic shock receiving fluid resuscitation Cv-aCO2/Ca-vO2.

Authors:  Huiling Zang; Xiaohui Shen; Shengchi Wang; Zhihong He; Hui Cheng
Journal:  Exp Ther Med       Date:  2019-08-28       Impact factor: 2.447

10.  Intrapulmonary right-left shunts in Guillain-Barré syndrome with severe dysautonomia.

Authors:  Marek Sykora; Jennifer Diedler; Werner Hacke; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.